In all these studies, a specific RA therapy (consisting in the use of disease modifying antirheumatic drugs [DMARDs] and/or TNF inhibitors) has always been part of the treatment, whereas in the present case, a specific therapy has never been carried out. The gene discussed is TNF; the disease is rheumatoid arthritis.